Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment (IMMPACT)
Congenital Heart Disease
About this trial
This is an interventional diagnostic trial for Congenital Heart Disease focused on measuring Congenital Heart Disease (CHD)
Eligibility Criteria
Inclusion Criteria:
- Patients over the age of 3 months with CHD HF who are candidates for MCS will be prospectively identified at the participating centers.
Exclusion Criteria:
- Any CHD-HF patient unable to tolerate a CMR or cardiac CT will be excluded.
Sites / Locations
- Children's National HospitalRecruiting
- University of FloridaRecruiting
- Children's Healthcare of AtlantaRecruiting
- Lurie Children's HospitalRecruiting
- University of IowaRecruiting
- Johns Hopkins
- Mayo ClinicRecruiting
- Washington UniversityRecruiting
- Montefiore Medical Center
- Columbia UniversityRecruiting
- Weill Cornell
- Duke University
- Cleveland ClinicRecruiting
- University of Virginia
- Seattle childrens
- LaCardio
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Group A - 3D models
Group B - Control
Group A will receive 3-D printed models will be used for pre-VAD planning. For patients in Group A, the surgeon will complete a questionnaire 1) after reviewing 2D imaging data and 2) after reviewing a patient specific 3D model. The investigators primary outcome measure will be an improvement in the clarity of cannula and VAD site demonstration. The investigators hypothesize that the 3D models will more clearly demonstrate the sites of cannula and VAD placement as compared to 2D imaging.
Group B will be the controls and will not receive a 3D model.